EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ANGLE's enterprise value is $23.54 Mil.
ANGLE's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $2.27 Mil. Therefore, ANGLE's EV-to-Revenue for today is 10.38.
The historical rank and industry rank for ANGLE's EV-to-Revenue or its related term are showing as below:
ANPCF'
s EV-to-Revenue Range Over the Past 10 Years
Min: -2.5 Med: 61.94 Max: 291.93
Current: 12.52
During the past 13 years, the highest EV-to-Revenue of ANGLE was 291.93. The lowest was -2.50. And the median was 61.94.
ANPCF's EV-to-Revenue is ranked worse than 83.26% of 227
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.02
vs ANPCF: 12.52
As of today (2024-04-27), ANGLE's stock price is $0.1964.
ANGLE's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.01. Therefore, ANGLE's PS Ratio for today is 21.82.
ANGLE EV-to-Revenue Historical Data
The historical data trend for ANGLE's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, ANGLE's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ANGLE's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where ANGLE's EV-to-Revenue falls into.
ANGLE's current Enterprise Value is $23.54 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ANGLE's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $2.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ANGLE's share price for today is $0.1964.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ANGLE EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of ANGLE's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANPCF has been successfully added to your 